In Vitro and in Vivo Pharmacological Models to Assess Demyelination and Remyelination

Neuropsychopharmacology - United Kingdom
doi 10.1038/npp.2008.145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Toxin-Based Models to Investigate Demyelination and Remyelination

Methods in Molecular Biology
GeneticsMolecular Biology
2019English

Coronavirus-Induced Demyelination and Spontaneous Remyelination

2005English

Lymphangiogenesis: In Vitro and in Vivo Models

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2009English

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination

Journal of Neuroscience
Neuroscience
2017English

Arrhythmia Models: In Vivo, in Vitro and in Silico

Drug Discovery Today: Disease Models
Drug DiscoveryMolecular Medicine
2009English

Key to Opening Kidney for in Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and in Vitro-In Vivo Extrapolation

AAPS Journal
Pharmaceutical Science
2016English

Developing in Vitro and in Vivo Models to Predict Drug-Induced Acute Allergic Adverse Reactions

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Demyelination Arrest and Remyelination Induced by Glatiramer Acetate Treatment of Experimental Autoimmune Encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

A Method to Assess Target Gene Involvement in Angiogenesis in Vitro and in Vivo Using Lentiviral Vectors Expressing shRNA

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy